![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 45, 41906-41912, November 9, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
¶, and
**
From the
Department of Molecular Genetics and Cell
Biology and the
Department of Radiation and Cellular Oncology,
University of Chicago, Chicago, Illinois 60637 and the
¶ Department of Biology, Graduate School of Science, Osaka
University, Toyonaka, Osaka 560-0043, Japan
Received for publication, June 15, 2001, and in revised form, September 5, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Dmc1 and Rad51 are eukaryotic RecA homologues
that are involved in meiotic recombination. The expression of Dmc1 is
limited to meiosis, whereas Rad51 is expressed in mitosis and meiosis. Dmc1 and Rad51 have unique and overlapping functions during meiotic recombination. Here we report the purification of the Dmc1 protein from
the budding yeast Saccharomyces cerevisiae and present
basic characterization of its biochemical activity. The protein has a
weak DNA-dependent ATPase activity and binds both
single-strand DNA (ssDNA) and double-strand DNA. Electrophoretic
mobility shift assays suggest that DNA binding by Dmc1 is cooperative.
Dmc1 renatures linearized plasmid DNA with first order reaction
kinetics and without requiring added nucleotide cofactor. In addition,
Dmc1 catalyzes strand assimilation of ssDNA oligonucleotides into
homologous supercoiled duplex DNA in a reaction promoted by ATP or the
non-hydrolyzable ATP analogue AMP-PNP.
Central to the mechanism of homologous recombination is the
recognition of homology and formation of hybrid DNA between two chromosomes. In bacteria, the RecA protein promotes hybrid DNA formation during recombination (1-3). RecA binds and coats
ssDNA1 to form a helical
nucleoprotein filament. This filament binds dsDNA to search for regions
homologous to the ssDNA contained within the filament. During the
search for homology, the dsDNA adopts an underwound and extended
conformation, creating unstacked base pairs that can be tested for
homology. RecA then catalyzes strand exchange, a reaction in which the
ssDNA contained within the filament displaces the identical strand in
the dsDNA and forms Watson-Crick base pairs with its complement.
Functions of RecA have been conserved in bacteriophage, prokaryotes,
archaea, and eukaryotes (4-6). Eukaryotes have at least two structural
and functional relatives of RecA, Rad51 and Dmc1 (7-10). Rad51 is
important for both mitotic and meiotic recombination whereas Dmc1
expression and function are meiosis-specific. Additional relatives of
Rad51 have been identified in yeast and vertebrates (reviewed in Ref.
11). Although a complex containing two of the five vertebrate Rad51
paralogues has been shown to function together to promote homologous
strand assimilation (12), additional data suggest that Rad51 paralogues
act as assembly factors for Rad51 (13-15). Genetic studies have
demonstrated that both Dmc1 and Rad51 can promote recombination in the
absence of the other (16, 17). Despite this partial redundancy of
function, Rad51 and Dmc1 have unique functions during recombination
that cooperate during a large fraction of recombination events
(16-19). Evidence for direct interaction between Dmc1 and Rad51 has
been reported for the human but not the yeast orthologues (20-22). The
mechanistic details and function of Dmc1-Rad51 cooperation during
recombination are unknown.
Like RecA, Rad51 from human and yeast has been shown to catalyze
homologous pairing and perform strand exchange activity (11, 23, 24).
Its activity is stimulated by accessory factors, including the
single-strand DNA binding protein RPA (replication protein A) and
proteins encoded by members of the RAD52 epistasis group
(11, 25). These factors help load Rad51 onto ssDNA and promote
unwinding of dsDNA targets during strand invasion and exchange. Rad51
forms helical nucleoprotein filaments in which the DNA is in an
underwound and extended conformation relative to the B form, indicating
that the structural framework underlying the strand invasion
process is conserved between Escherichia coli and eukaryotes
(26, 27).
Like yeast and human Rad51, human Dmc1 (HsDmc1) has been reported to
have homologous pairing activity (22, 28, 29), although the activity
reported is less robust than that of Rad51. The HsDmc1 protein has been
shown to form toroidal octomers that can bind DNA as a stack of rings
on the DNA (22, 30). Helical filaments have not been detected.
Discovery of the toroidal form of Dmc1 raises the possibility that the
functional form of Dmc1 differs from that of other members of the RecA
family. Direct evidence supporting this possibility has yet to be obtained.
In addition to promoting homology-mediated invasion of duplex, RecA is
able to renature complementary ssDNA strands, an activity that may
contribute to some types of recombination (31). Renaturation activity
has also been reported for HsRad51 (32). Furthermore, yeast Rad52 also
promotes renaturation, and this activity may be responsible for
Rad51-independent recombination events in mitotic cells (33-36).
Here, we describe the purification of Dmc1 protein from the budding
yeast Saccharomyces cerevisiae and biochemical
characterization of its function. Like RecA, Rad51, and HsDmc1, ScDmc1
binds both ssDNA and dsDNA and has DNA-dependent ATPase
activity. We show for the first time that Dmc1 promotes renaturation of
complementary ssDNA and does so with first order reaction kinetics like
RecA. We also show that ScDmc1 can promote homologous ssDNA strand
assimilation in duplex DNA.
Complementation and Recombination Frequency Assays--
To
determine if the Dmc1 protein remains functional in S. cerevisiae when modified by the addition of 6 histidine codons at the amino terminus, an HIS6-DMC1 allele
was constructed. This allele was inserted at the normal DMC1
locus by one-step transplacement. The KanMX4 gene was
located 643 bp 3' of the transcriptional stop codon, conferring
resistance to the antibiotic G418 (Sigma Chemical Co.). The
HIS6-DMC1::KanMX4
construct was transformed into the haploid strain DKB1586
(MATa; dmc1
The
HIS6-DMC1::KanMX4
and DMC1::KanMX4 strains were mated
with DKB760 (MAT Dmc1 Expression in E. coli--
An intronless derivative of
DMC1 was modified to encode an additional 6 histidine
residues at the amino terminus and placed under the control of a phage
T7 promoter (pET3a, Novagen) to create pNRB150. This plasmid was
chemically transformed into BLR(DE3)/pLysS E. coli cells
(Novagen), which carry a null mutation in the recA gene.
Cells were grown at 37 °C in Luria-Broth supplemented with 100 µg/ml ampicillin and 20 µg/ml chloramphenicol until the cells reached A540 = 0.3. Expression of Dmc1
was induced by the addition of 1.0 mM
isopropyl- Purification of Dmc1--
Frozen cells were rapidly thawed and
kept at 4 °C for the remainder of the purification. The thawed cells
were sonicated four times on a Cole-Parmer ultrasonic homogenizer
(Chicago, IL) for 30 s each at 30% duty cycle and output of 3 in
the presence of protease inhibitors (5 µg/ml antipain, 2 µg/ml
aprotinin, 100 ng/ml leupeptin, 100 µg/ml Pefabloc SC). Insoluble
material was removed by ultracentrifugation for 45 min at 25,000 rpm in
a Beckman 70 Ti rotor. The cleared lysate was incubated with Talon
resin (CLONTECH) that had been equilibrated in
buffer A. The resin was washed with TP buffer (20 mM
Tris-HCl, pH 7.5, 100 mM sodium phosphate, pH 7.5, 10%
glycerol, 2 mM BME). The protein-bound resin was then incubated with TP buffer containing 0.36 unit/µl of DNase I (Amersham Pharmacia Biotech), 2 mM MgCl2, and protease
inhibitors. The resin was washed with TP buffer and then with 50 mM imidazole, pH 7.9, in TP buffer. Dmc1 was eluted with
100 mM imidazole, pH 7.9, in TP buffer.
Protein eluted from the Talon resin was applied to Cibacron Blue
(Bio-Rad) equilibrated with TP buffer. The column was washed with 200 mM NaCl in buffer G (20 mM Hepes, pH 7.9, 10%
glycerol, 1 mM EDTA, 2 mM BME). Dmc1 was eluted
with 1.0 M NaCl in buffer G. The eluted protein was
dialyzed against 200 mM NaCl in buffer G. The dialyzed
fraction was then applied to Q-Sepharose (Amersham Pharmacia Biotech)
equilibrated in buffer G with 200 mM NaCl. Dmc1 was eluted
from the column with steps of 0.3, 0.5, 0.7, and 1.0 M NaCl
in buffer G.
Protein fractions from the 0.5 and 0.7 M NaCl elution were
combined and concentrated by dialysis into storage buffer (20 mM Hepes, pH 7.9, 50% glycerol, 0.7 M NaCl, 1 mM EDTA, 2 mM BME). Aliquots were frozen in
liquid N2 and stored at
Protein concentrations were determined by Bradford assay (Bio-Rad) and
by spectrophotometric analysis at 280 nm (Dmc1 has an extinction
coefficient of 12240 M DNA Substrates--
The plasmids pBluescript II SK (+), pUC18,
and pNRB252 used for biochemical assays were purified without DNA
denaturation from log phase cultures of E. coli by
lysozyme/Triton lysis followed by centrifugation in a cesium
chloride/ethidium bromide density gradient (37). Plasmid pNRB252 was
constructed by inserting the 429-bp EcoRV-BsrBI
fragment from pRS306 (38) into the HincII site of piAN7
(39). Oligo 18.1 is homologous to base pairs 400-455 of pUC18 (40),
and oligo 306.7 is homologous to base pairs 165-220 of the 429-bp
EcoRV-BsrBI fragment.
For ATPase assays, the viral strand of M13 was propagated in E. coli strain JM101 and prepared according to published methods (41). For DNA binding assays, replicative form I
All DNA was end-labeled with [ ATPase Assay--
Reactions (10 µl) contained circular
single-stranded M13 (0.3 mM nucleotide) in 20 mM Hepes, pH 7.5, 1 mM DTT, 1 mM
magnesium acetate, 100 µg/ml bovine serum albumin, and 0.1 mM [ DNA Binding Assay--
Reactions (15 µl) contained either 1.3 µM 32P-labeled linear ds Renaturation Assay--
32P-Labeled
heat-denatured linear pBluescript II SK (+) at various
concentrations was incubated with Dmc1 in 20 mM Hepes, pH 7.5, 10 mM magnesium acetate, 1 mM DTT, and 2 mM nucleotide cofactor. Aliquots of 25 µl were removed at
appropriate time points and treated with 0.1% SDS at 37 °C for 10 min. Following addition of SDS, samples were kept at 4 °C while
additional time points were taken. The samples were resolved on a 0.8%
agarose gel in 1× TAE buffer for 1 h at 10 V/cm. The gels were
dried on Whatman paper and analyzed by phosphorimaging.
Strand Assimilation Assay--
Dmc1 (0.54 µM) was
preincubated with either 32P-labeled oligo 18.1, 306.7, or
both (1.0 µM each) as in the DNA binding assays. Following preincubation, a mixture of pUC18 (12.3 µM) and
pNRB252 (6 µM) was added along with sufficient magnesium
acetate to give a final concentration of 10 mM. Oligos were
in 5-fold molar excess to dsDNA target sequence. The reactions were
incubated at 37 °C and stopped by the addition of SDS to a final
concentration of 0.08%. DNA from reaction mixtures was resolved on a
0.8% agarose gel in 1× TAE buffer for 14-16 h at 2.2 V/cm. Gels were
dried onto Whatman paper and analyzed by phosphorimaging.
Complementation of His6-Dmc1--
To aid in
purification, the full-length coding region of DMC1 was
tagged with His6. To ensure that the addition of 6 histidine residues to the amino terminus did not disrupt Dmc1 function, a strain was constructed that expressed only the
His6-tagged Dmc1 protein. This strain was assayed for
sporulation efficiency, spore viability, and the ability to generate
recombinant products. The strain expressing His6-Dmc1 was
indistinguishable from the wild type control in all three assays (Table
I). These data indicate that the
His6-Dmc1 protein is fully functional in vivo.
Purification of ScDmc1--
His6-tagged Dmc1 was
cloned into the phage T7 expression vector pET3a. The protein was
expressed and purified from an E. coli strain that allowed
inducible expression of the T7 RNA polymerase and carried a null allele
of the recA gene to avoid potential contamination of Dmc1
preparations with RecA. Dmc1 was purified to near homogeneity by three
chromatographic steps (see "Experimental Procedures"). A Coomassie
Blue-stained SDS-polyacrylamide gel electrophoresis gel of the purified
protein shows a single prominent band (Fig.
1A). Although there are
species of smaller molecular weight detected in the lysate by Western
blot, these did not bind to the Talon resin and the final fraction
contains little or none of these species as assayed by Western blot
(Fig. 1B).
Dmc1 has DNA-dependent ATPase Activity--
Dmc1
contains Walker A and B amino acid sequence motifs, which are present
in many proteins that bind ATP (42). Like other members of the RecA
family, the ability of Dmc1 to hydrolyze ATP to ADP and Pi
is stimulated in the presence of either ssDNA or dsDNA (Fig.
2). The presence of dsDNA only stimulates
the ATPase activity of Dmc1 to half the activity level stimulated by
ssDNA. Omission of DNA results in 13% relative to the maximal ATPase activity. The lower ATPase activity in the presence of dsDNA as compared with ssDNA is unlikely to be due to lack of binding of Dmc1 to
DNA, because all the Dmc1 should be bound to the DNA under the reaction
conditions employed (see below). The ATP turnover rate
(kcat) was calculated by generation of
Lineweaver-Burk plots. In two independent experiments, the
kcat was calculated to be 0.6 min Dmc1 Binds ssDNA and dsDNA--
The ATPase assays indicate that
Dmc1 interacts with DNA. The ability of Dmc1 to stably bind ssDNA and
dsDNA was assayed directly by electrophoretic mobility shift assays
(EMSAs). Dmc1 was able to bind both ssDNA and dsDNA forming complexes
that were stable enough to survive electrophoresis in agarose gels
without cross-linking (Fig. 3).
Incubation of ssDNA (2.6 µM nucleotide) in the presence
of ATP showed that below 0.126 µM Dmc1 there was little
shifting of DNA, although the mobility of a minor fraction of DNA was
slightly shifted. Increasing the concentration of Dmc1 from 0.126 to
0.28 µM resulted in a discrete shift in the mobility of
linear ss
Dmc1 did not result in an electrophoretic mobility shift of dsDNA at
concentrations below 0.28 µM. A small fraction of the DNA
was retarded after incubation with 0.28 µM DNA, whereas a discrete shift of all DNA was observed at 0.42 µM, which
corresponds to a monomer per base pair ratio of 1:6. The same shift in
mobility of DNA was observed after binding to Dmc1 at concentrations
ranging from 0.42 to 1.26 µM. However, a further 2-fold
increase in Dmc1 concentration from 1.26 to 2.5 µM
resulted in a further reduction in mobility of DNA. These data suggest
that Dmc1 binds to dsDNA with slightly less affinity than to ssDNA.
Consistent with this suggestion, binding to dsDNA was sensitive to
slightly lower concentrations of NaCl than binding to ssDNA (data not
shown). Unlike binding to ssDNA, binding to dsDNA required the presence
of a nucleotide cofactor, such as ATP, dATP, ADP, or a non-hydrolyzable
ATP analogue (data not shown).
Dmc1 Catalyzes Renaturation of Complementary Single
Strands--
To determine if it is able to promote ssDNA renaturation,
Dmc1 (0.35 µM) was incubated with 32P-labeled
heat-denatured linear plasmid DNA (pBluescript II SK(+), 1.2 µM bp = 2.4 µM nucleotide).
Spontaneous renaturation of the ssDNA was not detected during the time
period examined (Fig. 4A), but
Dmc1-dependent renaturation activity is readily detected at 0.5 min (Fig. 4B). Essentially all renatured products were
in the form of linear duplex as opposed to high molecular weight networks. Such networks are the predominant product of RecA-promoted renaturation under most conditions (31, 43, 44). The results suggest
that, under the conditions employed, the renatured products form
without multiple independent "nucleation" events on a single molecule.
Maximum Dmc1-dependent renaturation activity occurs at
ratios of Dmc1 to nucleotides between 1:10 and 1:40. (Fig.
4C). If saturation of ssDNA by Dmc1 occurs around 1 monomer
to two to three nucleotides (as suggested by the EMSAs), optimal
renaturation under these conditions occurs when less than 20% of the
ssDNA is bound to protein. Both lower and higher levels of Dmc1 reduce the level of renaturation.
To determine if the Dmc1-dependent renaturation reaction
proceeds with first or second order kinetics, the ratio of Dmc1 to nucleotide was kept at 1:14 and the concentration of heat-denatured linear pBluescript was varied over a 100-fold range (0.011-1.1 nM plasmid molecules). A log-log plot of the half times of
the renaturation reactions versus the initial concentration
of heat-denatured DNA yields a straight line with a slope of Dmc1 Promotes Homologous Strand Assimilation--
RecA can promote
assimilation of ssDNA into intact dsDNA (46, 47). The product of this
reaction survives deproteination and is likely to be a
"D-loop" in which the assimilated strand forms Watson
Crick base pairs with the complementary sequence on the target (48).
However, it is also possible that deproteination of homologously
paired complexes traps the single strand in a stable, non-B form
structure (49). For this reason we refrain from concluding that the
activity we observe with the assay is complete strand exchange.
The ability of Dmc1 to catalyze strand assimilation between ssDNA and
dsDNA was assayed using oligos homologous to super-coiled duplex
plasmids. Homologous joints formed between the oligo and the plasmid
are detected following gel electrophoresis. Because of the relatively
small size of the oligo compared with the super-coiled target plasmid,
the joint molecules have about the same electrophoretic mobility as
supercoiled dsDNA and are detected as a radioactive species at the
position of the supercoiled dsDNA following electrophoresis.
Dmc1 is able to catalyze assimilation of ssDNA into dsDNA in a
homology-dependent manner. Maximum strand assimilation
activity was observed after 10 min (Fig.
5A) and when AMP-PNP was used as a nucleotide cofactor (Fig. 5C). In the presence of two
super-coiled plasmids, only one of which contained a sequence
homologous to the oligo, joints were only detected between the oligo
and the plasmid containing the homologous sequence (Fig. 5B,
lanes 2 and 4). Although variable, ~20% of
maximum levels of product formation were detected in the presence of
ATP. Product formation was not detected in the absence of nucleotide
cofactor or when ATP
Optimal strand assimilation activity occurred at a Mg2+
concentration between 10 and 15 mM; there was a 2-fold
decrease in product formation at Mg2+ concentrations of 5 and 50 mM. Strand assimilation also required that the dsDNA
substrate be super-coiled; linearization of the plasmid at various
unique restriction sites abolished the signal. Strand assimilation
activity was not detected at concentrations of Dmc1 below 1/3
monomer/nucleotide. Additionally, optimal activity required
preincubation of Dmc1 with the ssDNA oligo before the addition of the
super-coiled dsDNA target. The optimum stoichiometry and sensitivity to
Mg2+concentration are similar to those reported for strand
assimilation by RecA and strand exchange by Rad51 (23, 47, 50, 51).
The results presented here add to the evidence that the function
of the meiosis-specific protein Dmc1 is closely related to E. coli RecA and eukaryotic Rad51. Like HsDmc1, ScDmc1 is a weak DNA-dependent ATPase, binds both dsDNA and ssDNA, and
promotes ssDNA assimilation into duplex DNA. We show for the first time that Dmc1 promotes efficient renaturation of complementary ssDNA strands.
Results of the EMSAs suggest Dmc1 binds DNA cooperatively. Gel shift
assays showed distinct shifts of DNA mobility only when a certain
protein level was achieved. These shifted species were unaltered by
further increases in Dmc1 concentration. This behavior is not expected
if monomers bind DNA strands in a non-cooperative manner. Such
situations predict that individual DNA molecules will bind different
amounts of proteins resulting in a gradual and non-uniform shift in
mobility until saturation is reached. The discrete shifts observed in
these experiments suggest that Dmc1 binds both ssDNA and dsDNA in a
cooperative manner, as shown previously for RecA and Rad51 (7,
52-54).
EMSAs suggest that Dmc1 saturates ssDNA and dsDNA at about 1:3
monomer/nucleotide and 1:6 monomer/base pairs, respectively. These
numbers are similar to those reported for RecA, which saturates DNA
at 1:6 monomers per nucleotide under some conditions and 1:3 under
others (Ref. 55, and references therein). The results are also similar
to results obtained for HsRad51, ScRad51, and HsDmc1 (7, 24, 26-28,
56). Further studies of Dmc1-DNA binding using methods that allow
accurate quantification of binding in solution are needed to determine
the degree of cooperativity and stoichiometry of Dmc1-DNA binding.
Dmc1 promotes efficient renaturation of complementary ssDNA with the
following characteristics: Optimal renaturation occurs at Dmc1 levels
that cover less than 20% of the ssDNA; deviation from this optimum
results in less efficient renaturation; and the reaction occurs with
first order kinetics. These properties are shared with RecA-mediated
renaturation (45) and are in contrast to spontaneous renaturation as
well as the renaturation reaction promoted by the yeast recombination
protein Rad52 (35). The first order kinetics suggest that the
rate-limiting step in renaturation of complementary ssDNA strands is
not the pairing of complementary strands but a later step that involves
conversion of a complex containing Dmc1 and two ssDNA strands to stable
duplex DNA (43). The ability of Dmc1 to promote annealing may result
from an ability to promote unstable protein-DNA aggregates and/or from
the ability of Dmc1 oligomers to bind 2 DNA strands simultaneously (43, 45).
In contrast to the renaturation activity, which did not require
nucleotide cofactor, the strand assimilation by Dmc1 required addition
of either ATP or the non-hydrolyzable analogue AMP-PNP. The finding
that AMP-PNP promotes strand assimilation by Dmc1 is consistent with
results obtained with RecA and Rad51, which indicate that strand
assimilation and strand exchange require a nucleotide cofactor but not
ATP hydrolysis (46, 57, 58). Effective nucleotide cofactors are
predicted to act as allosteric effectors causing Dmc1 to adopt a
conformation that is favorable for strand assimilation.
Although the renaturation activity of Dmc1 is quite efficient in
vitro, the precise relevance of this activity to Dmc1's function in vivo remains to be determined. The DNA at the sites of
meiotic double-strand breaks is rendered singled-stranded by nucleases. The two ssDNA ends invade an intact duplex chromatid to form
double-Holliday junctions (59). Both Dmc1 and Rad51 are required for
full levels of joint molecule formation in vivo. It is
possible that invasion of one ssDNA end by Rad51 forms a D-loop that is
enlarged by repair synthesis on the intact chromatid, forming a region
of ssDNA complementary to the ssDNA sequences on the second DNA end.
Dmc1 could catalyze annealing between the D-loop and the ssDNA region
from the second DNA end. However, we believe that this explanation
cannot fully account for Dmc1's in vivo recombination
activity. A rad51 mutant shows only a 3-fold reduction in
the formation of joint molecules, and this level of recombination
depends on DMC1+ (16). In addition, a
dmc1 mutant allele that contains a lysine to alanine
mutation in the putative ATP binding site of Dmc1 (i.e. the
"Walker box" motif) was indistinguishable from a null mutant, in
respect to promoting formation of meiotic
products.2 Thus nucleotide
binding is likely to be important for Dmc1 function in vivo.
Because strand assimilation but not single-strand annealing is effected
by the absence of nucleotide, it is unlikely that the Walker box
mutant's phenotype results from a defect in annealing activity alone.
We propose that, like other members of the RecA family, Dmc1 performs
strand invasion to form joint molecules by a mechanism distinct from,
but closely related to, the mechanism that promotes renaturation of DNA
in vitro.
Even under optimal conditions used here, the level of Dmc1's strand
assimilation activity was low; a maximum of 1% of oligo and 4% of
target duplex were present in joint molecules. It is important to use
caution in ascribing biological significance to the strand assimilation
activity of a protein when that activity is low. Nonetheless, we argue
that the assimilation activity of Dmc1 is biologically relevant for
three reasons. First, as discussed in the introduction, there is good
evidence that Dmc1 promotes the formation of homologous joint molecules
in vivo and does so in the absence of other proteins related
to RecA. Second, as discussed above, both Dmc1 recombination activity
in vivo and its strand assimilation activity in
vitro appear to depend on nucleotide cofactor. This property of
Dmc1 strand assimilation is shared with the efficient strand
assimilation reaction promoted by RecA. Finally, as discussed further
below, previous studies predict that the efficiency of Dmc1's strand
assimilation activity will be strongly dependent on accessory proteins.
Although further optimization of the reaction may increase strand
assimilation activity of Dmc1 in vitro, it is likely that the efficiency of the reaction is limited due to the absence of one or
more accessory proteins. This possibility is underscored by previous
studies on Rad51. In contrast to RecA, which can promote strand
assimilation in the absence of other proteins, Rad51's strand
assimilation activity requires one of two structurally related DNA
unwinding proteins, Rad54 or Tid1/Rdh54 (60-63). These unwinding
proteins have not been shown to possess helicase activity, but have
been shown to alter the topology of duplexes, probably by reducing the
twist of the dsDNA target. Because Dmc1-catalyzed strand assimilation
requires a super-coiled duplex target, local unwinding may be required
for Dmc1 to promote strand assimilation in the absence of other
proteins. Tid1/Rdh54 was isolated based on its interaction with Dmc1 in
a two-hybrid assay and subsequently shown to interact with Rad51 (64).
Cytological and genetic observations suggest that Tid1/Rdh54 stimulates
Dmc1 activity in vivo (19, 65). Thus, Dmc1 almost certainly
relies on Rdh54/Tid1 to alter the topology of the target duplex as it
promotes homologous strand assimilation in vivo. Dmc1 is
also likely to rely on factors that direct its assembly into oligomers
at the sites of meiotic double-strand breaks. A particularly
interesting possibility is that Dmc1's biochemical activity is
influenced by interaction with its partner recombinase Rad51, as
suggested by cytological and biochemical experiments (18, 20-22).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
::ARG4) to
create strain DKB1589. As a control, a
DMC1::KanMX4 construct (i.e.
an unmodified copy of DMC1) was also transplaced into
DKB1586 to create strain DKB1687. Proper integrants were detected by
screening transformants for loss of arginine prototrophy. Integration
into the correct position was confirmed by Southern blot analysis.
;
dmc1
::ARG4) to create diploid
strains DKB1688
(dmc1
::ARG4/HIS6-DMC1::KanMX4)
and DKB1689
(dmc1
::ARG4/ DMC1::KanMX4).
Both diploids were assayed for sporulation efficiency, spore viability,
and frequency of interhomologue recombination by previously published
methods (10).
-D-thiogalactopyranoside followed by a 1.5-h incubation at 30 °C. Cells were harvested by centrifugation, washed, resuspended in equal volume of buffer A (50 mM Tris-HCl, pH
7.5, 150 mM NaCl, 2 mM BME), frozen in liquid
nitrogen, and stored at
80 °C.
80 °C. The yield from 8.0 liters of cells was ~800 µg of Dmc1 protein.
1 cm
1 at
280 nm).
X 174 DNA (New
England BioLabs) was linearized with BsrBI followed
by treatment with alkaline phosphatase (New England BioLabs). The
reaction mixture was extracted with phenol and ethanol-precipitated.
The
X 174 viral strand was linearized by hybridizing oligos to
create a PstI site and a BsrBI site. The reaction
mixture was run on an agarose gel. The band was excised and purified
using the Geneclean kit (BIO 101, Inc., Vista, CA). For DNA
renaturation assays, pBluescript II SK (+) was linearized with
AccI followed by treatment with alkaline phosphatase. The
reaction mixture was extracted with phenol and
ethanol-precipitated.
-32P]ATP by T4
polynucleotide kinase (New England BioLabs) using a protocol provided
by the supplier. Radiolabeled DNA was purified from unincorporated
nucleotide using a G25 MicroSpin column (Amersham Pharmacia Biotech),
and the specific activity was adjusted to roughly 2.5 × 1010 cpm/µmol by addition of unlabeled DNA.
Concentrations of nucleic acids are given in moles of nucleotide for
ssDNA or moles of base pairs for dsDNA.
-32P]ATP. The turnover rate was
determined by calculating the Vmax based on a
50-fold range of ATP concentration. Reactions were started by the
addition of the appropriate amount of Dmc1 and incubated at 37 °C.
At the indicated time points, 1.0-µl aliquots were taken and spotted
onto thin layer chromatography plates (CEL300 PEI, Machery-Nagel). The
plates were developed in 850 mM potassium phosphate, pH
3.4, dried, analyzed using a Storm PhosphorImager (Molecular Dynamics),
and quantified using ImageQuant version 4.0 (Molecular Dynamics).
X 174 or 2.6 µM 32P-labeled linear ss
X 174, 20 mM Hepes, pH 7.5, 1 mM DTT, 1 mM magnesium acetate, and 2 mM ATP. Reactions were started by
the addition of the appropriate amount of Dmc1 and incubated for 5 min
at 37 °C. Reaction were analyzed by electrophoresis on an 0.8%
agarose gels for 1 h at 10 V/cm using 1× Tris acetate-EDTA (TAE)
running buffer containing Tris-HCl reduced to 10 mM. The gel was dried onto Whatman paper and developed on Kodak BioMax MS film.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Complementation of His6-tagged Dmc1

View larger version (80K):
[in a new window]
Fig. 1.
Overexpression and purification of
His6-Dmc1 from E. coli.
A, lanes 1 and 8, molecular
mass markers with sizes indicated in kDa. Lanes 2 and
3, total cell lysates before and after induction with
isopropyl-1-thio-
-D-galactopyranoside. Lane
4, unbound protein after incubation with Talon. Lanes
5-7, ScDmc1 eluted from Talon resin, Cibacron blue, and
Q-Sepharose columns. Lane 7 contains 5 µg of the purified
protein. Samples were run on a 10% SDS-polyacrylamide gel
electrophoresis gel and stained with Coomassie Blue. B,
Western blot of cellular proteins before and after induction with
isopropyl-1-thio-
-D-galactopyranoside (lanes
1 and 2) and 250 ng of purified His6-Dmc1
using affinity-purified anti-Dmc1 antibodies.
1
and 0.8 min
1, giving an average of 0.7 min
1. Although this is lower than the turnover rate for
RecA (kcat = 30 min
1), it is
similar to the kcat of human and yeast Rad51
(kcat = 0.16 min
1 and 0.7 min
1, respectively) (23, 24) and human Dmc1
(kcat = 1.5 min
1 and 0.7 min
1) (28, 29).

View larger version (22K):
[in a new window]
Fig. 2.
ScDmc1 protein has DNA-dependent
ATPase activity. Purified Dmc1 protein (2.7 µM) was
incubated with 1 mM [
-32P]ATP in a
10.0-µl reaction mixture containing 20.0 mM Hepes, pH
7.5, 1 mM DTT, 1 mM magnesium acetate, and 100 µg/ml bovine serum albumin. The reaction was performed in the
presence of 0.3 mM circular single-stranded M13 (
), 0.3 mM circular double-stranded M13 (
), or in the absence of
DNA (
). 1.0-µl aliquots were removed at indicated time points and
developed as described under "Experimental Procedures."

View larger version (52K):
[in a new window]
Fig. 3.
Dmc1 binds ssDNA and dsDNA. Increasing
amounts of Dmc1 was added to either A, 2.6 µM
32P-labeled linear ss
X 174 or B, 1.3 µM 32P-labeled linear ds
X 174 in a
15.0-µl reaction mixture containing 20.0 mM Hepes, pH
7.5, 1 mM DTT, 1 mM magnesium acetate, and 2 mM ATP. The reaction was incubated at 37 °C. Protein:DNA
complexes were separated on an agarose gel and visualized by
autoradiography. The ratios of nucleotides per monomer of Dmc1 or base
pairs per monomer of Dmc1 are given below each lane.
X 174. The lowest concentration at which the shift was
observed corresponds to a molar ratio of 1 monomer per 9 nucleotides.
Further increasing the Dmc1 concentration resulted in a gradual
increase in the mobility of the ssDNA to a plateau that corresponds to a monomer per nucleotide ratio of 1:2 to 1:3. Binding to
ssDNA was not substantially altered when nucleotide cofactor was
omitted from reactions (data not shown).

View larger version (39K):
[in a new window]
Fig. 4.
Dmc1 renatures complementary ssDNA strands
with first order reaction kinetics. Heat-denatured
32P-labeled linear pBluescript II SK(+) was incubated
A, in the absence of or B, in the presence of
Dmc1 at 37 °C. Aliquots were removed at the indicated time points
and deproteinized by the addition of SDS to 0.1%. The reaction
products were separated on an agarose gel and developed as described
under "Experimental Procedures." C, dependence of
renaturation on Dmc1 concentration. Product formation was measured
after 10 min. D, kinetics of the Dmc1-dependent
renaturation activity in the presence of AMP-PNP (
) or in the
absence of any nucleotide cofactor (
). The logarithm of the
half-time (ln t1/2) of the renaturation activity was
plotted as a function of the logarithm of the initial molar
concentration of the dsDNA.
0.097
(Fig. 4D). The log-log plot in the absence of nucleotide
cofactor or in the presence of other nucleotide cofactors produced
similar values (Fig. 4D and data not shown). Because the
slope of the plot did not differ significantly from 0, the results
indicate that the Dmc1-dependent renaturation is a first
order reaction, like RecA-dependent renaturation (44, 45).
A slope of
1 is expected if the reaction proceeds via second order
kinetics as is the case for non-enzymatic renaturation. Under the
conditions of our experiments the Dmc1-dependent
renaturation reaction did not require ATP hydrolysis nor was the
efficiency substantially dependent on added nucleotide. Although
RecA-dependent renaturation is more efficient in the
presence of ATP under some conditions, both RecA and Rad51 have also
been found to promote renaturation in the absence of hydrolysis (32,
45). The first order rate constant for renaturation was determined to
be 0.35 min
1, a value similar to values reported for RecA
(45).
S was substituted for AMP-PNP (Fig.
5C). This failure of ATP
S to support strand assimilation
did not result from failure of the nucleotide to bind Dmc1, because it
inhibited Dmc1's ATPase activity under similar conditions (data not
shown).

View larger version (32K):
[in a new window]
Fig. 5.
Dmc1 catalyzes homologous assimilation of
ssDNA into supercoiled dsDNA plasmid. A, time course
analysis of strand assimilation. Dmc1 was preincubated with oligo 18.1 before the addition of pUC18. Aliquots were removed at the indicated
time points and deproteinized by the addition of SDS to 0.1%.
B, Strand assimilation is homology-dependent.
Dmc1 (0.27 µM) was preincubated with either oligo 18.1 (lane 2) or oligo 306.7 (lane 4), or Dmc1 (0.54 µM) was preincubated with both oligos (lane 3)
before the addition of a mixture of two dsDNA plasmids. No joint
molecules were detected in the absence of Dmc1 (lane 1). The
reaction was incubated at 37 °C and deproteinized with SDS at a
final concentration of 0.08%. The joint molecules were resolved on a
0.8% agarose gel and developed as described under "Experimental
Procedures." C, joint molecule formation is efficient in
the presence of AMP-PNP. Time course of joint molecule product
formation was analyzed in the presence of AMP-PNP (
), ATP (
), no
nucleotide cofactor (
), or no Dmc1 (
). The percentage of joint
molecules formed is given respective to the maximum level of joint
molecules formed in the presence of AMP-PNP.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Mike Cox, Steve Kowalczykowski, Sue Lindquist, Pheobe Rice, Paul Mueller, and Lucia Rothman-Denes for helpful discussions during the course this work. We also thank Patrick Sung for advice and for critical reading of an earlier version of this manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by NIGMS, National Institutes of Health Grant GM50936 (to D. K. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ A Howard Hughes Medical Institute Predoctoral Fellow.
** To whom correspondence should be addressed: University of Chicago, Cummings Life Science Center, 920 E. 58th St., Chicago, IL 60637. Tel.: 773-702-9211; Fax: 773-834-9064; E-mail: dbishop@midway.uchicago.edu.
Published, JBC Papers in Press, September 10, 2001, DOI 10.1074/jbc.M105563200
2 T. Holzen and D. K. Bishop, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ssDNA, single-stranded DNA;
dsDNA, double-stranded DNA;
BME, 2-mercaptoethanol;
DTT, dithiothreitol;
AMP-PNP, adenosine
5'-(
,
-imino)triphosphate;
ATP
S, adenosine
5'-O-thiotriphosphate;
bp, base pair(s);
EMSA, electrophoretic mobility shift assay.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Radding, C. M.
(1991)
J. Biol. Chem.
266,
5355-5358 |
| 2. |
Kowalczykowski, S. C.,
Dixon, D. A.,
Eggleston, A. K.,
Lauder, S. D.,
and Rehrauer, W. M.
(1994)
Microbiol. Rev.
58,
401-465 |
| 3. | Roca, A. I., and Cox, M. M. (1997) Prog. Nucleic Acids Res. Mol. Biol. 56, 129-223[Medline] [Order article via Infotrieve] |
| 4. | Baumann, P., and West, S. C. (1998) Trends Biochem. Sci. 23, 247-251[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Bianco, P. R., Tracy, R. B., and Kowalczykowski, S. C. (1998) Front. Biosci. 3, D570-D603[Medline] [Order article via Infotrieve] |
| 6. | Sung, P., Trujillo, K. M., and Van Komen, S. (2000) Mutat. Res. 451, 257-275[Medline] [Order article via Infotrieve] |
| 7. | Shinohara, A., Ogawa, H., and Ogawa, T. (1992) Cell 69, 457-470[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Basile, G.,
Aker, M.,
and Mortimer, R. K.
(1992)
Mol. Cell. Biol.
12,
3235-3246 |
| 9. |
Aboussekhra, A.,
Chanet, R.,
Adjiri, A.,
and Fabre, F.
(1992)
Mol. Cell. Biol.
12,
3224-3234 |
| 10. | Bishop, D. K., Park, D., Xu, L., and Kleckner, N. (1992) Cell 69, 439-456[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Gasior, S. L.,
Olivares, H.,
Ear, U.,
Hari, D. M.,
Weichselbaum, R.,
and Bishop, D. K.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
8411-8418 |
| 12. |
Kurumizaka, H.,
Ikawa, S.,
Nakada, M.,
Eda, K.,
Kagawa, W.,
Takata, M.,
Takeda, S.,
Yokoyama, S.,
and Shibata, T.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
5538-5543 |
| 13. |
Bishop, D. K.,
Ear, U.,
Bhattacharyya, A.,
Calderone, C.,
Beckett, M.,
Weichselbaum, R. R.,
and Shinohara, A.
(1998)
J. Biol. Chem.
273,
21482-21488 |
| 14. |
Takata, M.,
Sasaki, M. S.,
Sonoda, E.,
Fukushima, T.,
Morrison, C.,
Albala, J. S.,
Swagemakers, S. M.,
Kanaar, R.,
Thompson, L. H.,
and Takeda, S.
(2000)
Mol. Cell. Biol.
20,
6476-6482 |
| 15. |
Takata, M.,
Sasaki, M. S.,
Tachiiri, S.,
Fukushima, T.,
Sonoda, E.,
Schild, D.,
Thompson, L. H.,
and Takeda, S.
(2001)
Mol. Cell. Biol.
21,
2858-2866 |
| 16. | Schwacha, A., and Kleckner, N. (1997) Cell 90, 1123-1135[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Shinohara, A., Gasior, S., Ogawa, T., Kleckner, N., and Bishop, D. K. (1997) Genes Cells 2, 615-629[Abstract] |
| 18. | Bishop, D. K. (1994) Cell 79, 1081-1092[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Shinohara, M.,
Gasior, S. L.,
Bishop, D. K.,
and Shinohara, A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
10814-10819 |
| 20. |
Tarsounas, M.,
Morita, T.,
Pearlman, R. E.,
and Moens, P. B.
(1999)
J. Cell Biol.
147,
207-220 |
| 21. |
Terasawa, M.,
Shinohara, A.,
Hotta, Y.,
Ogawa, H.,
and Ogawa, T.
(1995)
Genes Dev.
9,
925-934 |
| 22. | Masson, J. Y., Davies, A. A., Hajibagheri, N., Van Dyck, E., Benson, F. E., Stasiak, A. Z., Stasiak, A., and West, S. C. (1999) EMBO J. 18, 6552-6560[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Sung, P.
(1994)
Science
265,
1241-1243 |
| 24. | Baumann, P., Benson, F. E., and West, S. C. (1996) Cell 87, 757-766[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Shinohara, A., and Ogawa, T. (1999) Mutat. Res. 435, 13-21[Medline] [Order article via Infotrieve] |
| 26. |
Ogawa, T., Yu, X.,
Shinohara, A.,
and Egelman, E. H.
(1993)
Science
259,
1896-1899 |
| 27. | Benson, F. E., Stasiak, A., and West, S. C. (1994) EMBO J. 13, 5764-5771[Medline] [Order article via Infotrieve] |
| 28. |
Li, Z.,
Golub, E. I.,
Gupta, R.,
and Radding, C. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11221-11226 |
| 29. |
Gupta, R. C.,
Golub, E.,
Bi, B.,
and Radding, C. M.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
8433-8439 |
| 30. |
Passy, S. I., Yu, X.,
Li, Z.,
Radding, C. M.,
Masson, J. Y.,
West, S. C.,
and Egelman, E. H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
10684-10688 |
| 31. |
Weinstock, G. M.,
McEntee, K.,
and Lehman, I. R.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
126-130 |
| 32. |
Gupta, R. C.,
Bazemore, L. R.,
Golub, E. I.,
and Radding, C. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
463-468 |
| 33. | Rattray, A. J., and Symington, L. S. (1994) Genetics 138, 587-595[Abstract] |
| 34. | Ivanov, E. L., Sugawara, N., Fishman-Lobell, J., and Haber, J. E. (1996) Genetics 142, 693-704[Abstract] |
| 35. |
Mortensen, U. H.,
Bendixen, C.,
Sunjevaric, I.,
and Rothstein, R.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10729-10734 |
| 36. | Shinohara, A., Shinohara, M., Ohta, T., Matsuda, S., and Ogawa, T. (1998) Genes Cells 3, 145-156[Abstract] |
| 37. |
Kolodner, R.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
4847-4851 |
| 38. |
Sikorski, R. S.,
and Hieter, P.
(1989)
Genetics
122,
19-27 |
| 39. | Huang, H. V., Little, P. F., and Seed, B. (1988) Bio/Technology 10, 269-283[Medline] [Order article via Infotrieve] |
| 40. |
Hsieh, P.,
Camerini-Otero, C. S.,
and Camerini-Otero, R. D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6492-6496 |
| 41. | Messing, J. (1983) Methods Enzymol. 101, 20-78[Medline] [Order article via Infotrieve] |
| 42. | Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951[Medline] [Order article via Infotrieve] |
| 43. | McEntee, K. (1985) Biochemistry 24, 4345-4351[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Bryant, F. R., Menge, K. L., and Nguyen, T. T. (1989) Biochemistry 28, 1062-1069[CrossRef][Medline] [Order article via Infotrieve] |
| 45. |
Bryant, F. R.,
and Lehman, I. R.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
297-301 |
| 46. |
McEntee, K.,
Weinstock, G. M.,
and Lehman, I. R.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
2615-2619 |
| 47. |
Shibata, T.,
DasGupta, C.,
Cunningham, R. P.,
and Radding, C. M.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
1638-1642 |
| 48. |
Adzuma, K.
(1992)
Genes Dev.
6,
1679-1694 |
| 49. | Stasiak, A. (1992) Mol. Microbiol. 6, 3267-3276[CrossRef][Medline] [Order article via Infotrieve] |
| 50. |
Shibata, T.,
DasGupta, C.,
Cunningham, R. P.,
Williams, J. G.,
Osber, L.,
and Radding, C. M.
(1981)
J. Biol. Chem.
256,
7565-7572 |
| 51. | Sung, P., and Robberson, D. L. (1995) Cell 82, 453-461[CrossRef][Medline] [Order article via Infotrieve] |
| 52. | Silver, M. S., and Fersht, A. R. (1982) Biochemistry 21, 6066-6072[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | Menetski, J. P., and Kowalczykowski, S. C. (1989) Biochemistry 28, 5871-5881[CrossRef][Medline] [Order article via Infotrieve] |
| 54. | De Zutter, J. K., and Knight, K. L. (1999) J. Mol. Biol. 293, 769-780[CrossRef][Medline] [Order article via Infotrieve] |
| 55. |
Lauder, S. D.,
and Kowalczykowski, S. C.
(1991)
J. Biol. Chem.
266,
5450-5458 |
| 56. |
Namsaraev, E. A.,
and Berg, P.
(1998)
J. Biol. Chem.
273,
6177-6182 |
| 57. |
Rehrauer, W. M.,
and Kowalczykowski, S. C.
(1993)
J. Biol. Chem.
268,
1292-1297 |
| 58. |
Sung, P.,
and Stratton, S. A.
(1996)
J. Biol. Chem.
271,
27983-27986 |
| 59. | Schwacha, A., and Kleckner, N. (1995) Cell 83, 783-791[CrossRef][Medline] [Order article via Infotrieve] |
| 60. |
Petukhova, G.,
Van Komen, S.,
Vergano, S.,
Klein, H.,
and Sung, P.
(1999)
J. Biol. Chem.
274,
29453-29462 |
| 61. | Mazin, A. V., Bornarth, C. J., Solinger, J. A., Heyer, W. D., and Kowalczykowski, S. C. (2000) Mol. Cell 6, 583-592[CrossRef][Medline] [Order article via Infotrieve] |
| 62. | Van Komen, S., Petukhova, G., Sigurdsson, S., Stratton, S., and Sung, P. (2000) Mol. Cell 6, 563-572[CrossRef][Medline] [Order article via Infotrieve] |
| 63. |
Petukhova, G.,
Sung, P.,
and Klein, H.
(2000)
Genes Dev.
14,
2206-2215 |
| 64. | Dresser, M. E., Ewing, D. J., Conrad, M. N., Dominguez, A. M., Barstead, R., Jiang, H., and Kodadek, T. (1997) Genetics 147, 533-544[Abstract] |
| 65. | Shinohara, M., Shita-Yamaguchi, E., Buerstedde, J. M., Shinagawa, H., Ogawa, H., and Shinohara, A. (1997) Genetics 147, 1545-1556[Abstract] |
This article has been cited by other articles:
![]() |
C. J. Tsai, D. G. Mets, M. R. Albrecht, P. Nix, A. Chan, and B. J. Meyer Meiotic crossover number and distribution are regulated by a dosage compensation protein that resembles a condensin subunit Genes & Dev., January 15, 2008; 22(2): 194 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Pezza, O. N. Voloshin, F. Vanevski, and R. D. Camerini-Otero Hop2/Mnd1 acts on two critical steps in Dmc1-promoted homologous pairing Genes & Dev., July 15, 2007; 21(14): 1758 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Symington and W.-D. Heyer Some disassembly required: role of DNA translocases in the disruption of recombination intermediates and dead-end complexes Genes & Dev., September 15, 2006; 20(18): 2479 - 2486. [Full Text] [PDF] |
||||
![]() |
T. M. Holzen, P. P. Shah, H. A. Olivares, and D. K. Bishop Tid1/Rdh54 promotes dissociation of Dmc1 from nonrecombinogenic sites on meiotic chromatin Genes & Dev., September 15, 2006; 20(18): 2593 - 2604. [Full Text] [PDF] |
||||
![]() |
N. Sarai, W. Kagawa, T. Kinebuchi, A. Kagawa, K. Tanaka, K. Miyagawa, S. Ikawa, T. Shibata, H. Kurumizaka, and S. Yokoyama Stimulation of Dmc1-mediated DNA strand exchange by the human Rad54B protein Nucleic Acids Res., September 11, 2006; 34(16): 4429 - 4437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Pezza, G. V. Petukhova, R. Ghirlando, and R. D. Camerini-Otero Molecular Activities of Meiosis-specific Proteins Hop2, Mnd1, and the Hop2-Mnd1 Complex J. Biol. Chem., July 7, 2006; 281(27): 18426 - 18434. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sheridan and D. K. Bishop Red-Hed regulation: recombinase Rad51, though capable of playing the leading role, may be relegated to supporting Dmc1 in budding yeast meiosis. Genes & Dev., |